ANGIOTENSIN CONVERTING ENZYME INHIBITOR REDUCES THE INCIDENCE OF ATRIAL FIBRILLATION IN HEART FAILURE WITH PRESERVED EJECTION FRACTION PATIENTS: A RETROSPECTIVE COHORT STUDY FROM THE TREATMENT OF PRESERVED CARDIAC FUNCTION HEART FAILURE WITH AN ALDOSTERONE ANTAGONIST TRIAL

Heart failure (HF) and atrial fibrillation (AF) share several risk factors including coronary artery disease, hypertension, smoking, obesity, diabetes, and renal disease, as well as common pathophysiologic pathway involving activation of the renin-angiotensin-aldosterone system, maladaptive atrial